Eagle Pharma To Discuss Third Quarter 2016 Financial Results On November 9, 2016
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. ("Eagle" or “the Company”) (Nasdaq:EGRX) announced today that the Company will release its 2016 third quarter financial results on Wednesday, November 9, 2016, before the market opens.
Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host a conference call to discuss the results as follows:
Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host a conference call to discuss the results as follows: